View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

   reports
Guy Sips ... (+5)
  • Guy Sips
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Thomas Vranken
  • Wim Lewi
UCB UCB S.A.
BAR BARCO NV
MAAT MAAT PHARMA SA
ONWD ONWARD MEDICAL NV
01/09/25 January 9, 2025 1 EN
Christophe-Raphaël Ganet ... (+2)
  • Christophe-Raphaël Ganet
  • Thomas Zlowodzki
IFX INFINEON TECHNOLOGIES AG
FAGR FAGRON SA
ELG ELMOS SEMICONDUCTOR SE
TPE PVA TEPLA AG
SOI SOITEC SA
ASM ASM INTERNATIONAL N.V.
AIXA AIXTRON SE
PFV PFEIFFER VACUUM TECHNOLOGY AG
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
SLIGR SLIGRO FOOD GROUP N.V.
WAF SILTRONIC AG
MELE MELEXIS NV
SMHN SUESS MICROTEC AG
CSM CORBION NV
VACN VAT GROUP AG
XFAB X-FAB SILICON FOUNDRIES SE
ASML ASML HOLDING NV
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
WOLF SOCIETE LDC SOCIETE ANONYME
ALKAL KALRAY SA
JEN JENOPTIK AG
ARM ARM HOLDINGS PLC
AMS AMS-OSRAM AG
01/07/25 January 7, 2025 1 EN
Christophe-Raphaël Ganet ... (+3)
  • Christophe-Raphaël Ganet
  • Jerôme Bodin
  • Thomas Zlowodzki
IFX INFINEON TECHNOLOGIES AG
DGE DIAGEO PLC
SW SODEXO SA
VIV VIVENDI SE
ELG ELMOS SEMICONDUCTOR SE
TPE PVA TEPLA AG
AIR AIRBUS SE
SOI SOITEC SA
ASM ASM INTERNATIONAL N.V.
AIXA AIXTRON SE
PFV PFEIFFER VACUUM TECHNOLOGY AG
ACKB ACKERMANS & VAN HAAREN NV
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
WAF SILTRONIC AG
MELE MELEXIS NV
SMHN SUESS MICROTEC AG
VACN VAT GROUP AG
XFAB X-FAB SILICON FOUNDRIES SE
ASML ASML HOLDING NV
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
ALKAL KALRAY SA
JEN JENOPTIK AG
INPST INPOST S.A.
ARM ARM HOLDINGS PLC
AMS AMS-OSRAM AG
01/07/25 January 7, 2025 1 EN
Bruno Cavalier ... (+4)
  • Bruno Cavalier
  • Christophe-Raphaël Ganet
  • Jerôme Bodin
  • Thomas Zlowodzki
IFX INFINEON TECHNOLOGIES AG
DGE DIAGEO PLC
SW SODEXO SA
VIV VIVENDI SE
ELG ELMOS SEMICONDUCTOR SE
TPE PVA TEPLA AG
AIR AIRBUS SE
SOI SOITEC SA
ASM ASM INTERNATIONAL N.V.
AIXA AIXTRON SE
PFV PFEIFFER VACUUM TECHNOLOGY AG
ACKB ACKERMANS & VAN HAAREN NV
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
WAF SILTRONIC AG
MELE MELEXIS NV
SMHN SUESS MICROTEC AG
VACN VAT GROUP AG
XFAB X-FAB SILICON FOUNDRIES SE
ASML ASML HOLDING NV
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
ALKAL KALRAY SA
JEN JENOPTIK AG
INPST INPOST S.A.
ARM ARM HOLDINGS PLC
AMS AMS-OSRAM AG
01/07/25 January 7, 2025 1 FR
Christophe-Raphaël Ganet ... (+2)
  • Christophe-Raphaël Ganet
  • Thomas Zlowodzki
IFX INFINEON TECHNOLOGIES AG
FAGR FAGRON SA
ELG ELMOS SEMICONDUCTOR SE
TPE PVA TEPLA AG
SOI SOITEC SA
ASM ASM INTERNATIONAL N.V.
AIXA AIXTRON SE
PFV PFEIFFER VACUUM TECHNOLOGY AG
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
SLIGR SLIGRO FOOD GROUP N.V.
WAF SILTRONIC AG
MELE MELEXIS NV
SMHN SUESS MICROTEC AG
CSM CORBION NV
VACN VAT GROUP AG
XFAB X-FAB SILICON FOUNDRIES SE
ASML ASML HOLDING NV
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
WOLF SOCIETE LDC SOCIETE ANONYME
ALKAL KALRAY SA
JEN JENOPTIK AG
ARM ARM HOLDINGS PLC
AMS AMS-OSRAM AG
01/07/25 January 7, 2025 1 FR
Martin Marandon-Carlhian ... (+2)
  • Martin Marandon-Carlhian
  • Stephane Houri
IFX INFINEON TECHNOLOGIES AG
ELG ELMOS SEMICONDUCTOR SE
TPE PVA TEPLA AG
SOI SOITEC SA
ASM ASM INTERNATIONAL N.V.
AIXA AIXTRON SE
PFV PFEIFFER VACUUM TECHNOLOGY AG
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
WAF SILTRONIC AG
MELE MELEXIS NV
SMHN SUESS MICROTEC AG
VACN VAT GROUP AG
XFAB X-FAB SILICON FOUNDRIES SE
ASML ASML HOLDING NV
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
ALKAL KALRAY SA
JEN JENOPTIK AG
ARM ARM HOLDINGS PLC
AMS AMS-OSRAM AG
01/07/25 January 7, 2025 1 EN
Jacob Mekhael ... (+4)
  • Jacob Mekhael
  • Michiel Declercq
  • Thomas Vranken
  • Wim Lewi
FAGR FAGRON SA
TKWY JUST EAT TAKEAWAY.COM N.V.
SEQUA SEQUANA MEDICAL
SHUR SHURGARD SELF STORAGE LIMITED
01/07/25 January 7, 2025 1 EN
Martin Marandon-Carlhian ... (+2)
  • Martin Marandon-Carlhian
  • Stephane Houri
IFX INFINEON TECHNOLOGIES AG
ELG ELMOS SEMICONDUCTOR SE
TPE PVA TEPLA AG
SOI SOITEC SA
ASM ASM INTERNATIONAL N.V.
AIXA AIXTRON SE
PFV PFEIFFER VACUUM TECHNOLOGY AG
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
WAF SILTRONIC AG
MELE MELEXIS NV
SMHN SUESS MICROTEC AG
VACN VAT GROUP AG
XFAB X-FAB SILICON FOUNDRIES SE
ASML ASML HOLDING NV
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
ALKAL KALRAY SA
JEN JENOPTIK AG
ARM ARM HOLDINGS PLC
AMS AMS-OSRAM AG
01/07/25 January 7, 2025 1 FR
Jacob Mekhael
  • Jacob Mekhael
PREMIUM
SEQUA SEQUANA MEDICAL

Sequana Medical FIRST LOOK: Publishes 6-month alfapump results in live...

Sequana announced that the previously reported 6-month data from the pivotal POSEIDON study of the alfapump in recurrent or refractory ascites due to liver cirrhosis was published in the American Journal of Gastroenterology. This follows the recent FDA approval obtained for the alfapump in December 2024. Sequana expects US commercial launch to take place in 2H25 subject to additional financing to extend the company's cash runway beyond 1Q25.

01/07/25 January 7, 2025 1 EN
ING Helpdesk
  • ING Helpdesk
PREMIUM
GIMB GIMV NV
AALB AALBERTS N.V. ... (+4)

Benelux Morning Notes

Aalberts: M&A is back. Ahold Delhaize: Acquisition of Profi Rom completed. Gimv: A Christmas present. Kinepolis: US/Canada box office at 85% of pre Covid level, France at 92% in December

GIMB GIMV NV
AALB AALBERTS N.V.
KIN KINEPOLIS GROUP NV
AD KONINKLIJKE AHOLD DELHAIZE N.V.
01/06/25 January 6, 2025 1 EN
 PRESS RELEASE
Free
AGS AGEAS SA/NV

Ageas reports on the progress of share buy-back programme

Ageas reports on the progress of share buy-back programme Further to the initiation of the share buy-back programme announced on 28 August 2024, Ageas reports the purchase of 21,749 Ageas shares in the period from 23-12-2024 until 27-12-2024. DateNumber ofSharesTotal amount(EUR)Average price(EUR)Lowest price(EUR)Highest price(EUR)23-12-20248,321383,15546.0545.8046.1224-12-2024-----25-12-2024-----26-12-20247,613352,51846.3046.1046.4027-12-20245,815268,46646.1745.9446.52Total21,7491,004,14046.1745.8046.52 Since the start of the share buy-back programme on 16 September 2024, Ageas has bought b...

December 30, 2024 1 EN
 PRESS RELEASE
Free
AGS AGEAS SA/NV

Ageas rapporteert over de inkoop van eigen aandelen

Ageas rapporteert over de inkoop van eigen aandelen Naar aanleiding van het aandelen-inkoopprogramma dat op 28 augustus 2024 aangekondigd werd, maakt Ageas bekend dat er 21.749 eigen aandelen ingekocht werden tussen 23-12-2024 en 27-12-2024. DatumAantalaandelenTotaal Bedrag(EUR)Gemiddelde koers(EUR)Laagste koers(EUR)Hoogste koers(EUR)23-12-20248.321383.15546,0545,8046,1224-12-2024-----25-12-2024-----26-12-20247.613352.51846,3046,1046,4027-12-20245.815268.46646,1745,9446,52Totaal21.7491.004.14046,1745,8046,52 Vanaf de start van het aandelen-inkoopprogramma op 16 september 2024 heeft Ageas ee...

December 30, 2024 1 EN
Hilde Van Boxstael ... (+3)
  • Hilde Van Boxstael
  • Thomas Vranken
  • Wim Lewi
HYL HYLORIS PHARMACEUTICALS
12/30/24 December 30, 2024 1 EN
Hilde Van Boxstael ... (+3)
  • Hilde Van Boxstael
  • Thomas Vranken
  • Wim Lewi
AALB AALBERTS N.V.
ARGX ARGEN-X SE
HYL HYLORIS PHARMACEUTICALS
12/27/24 December 27, 2024 1 EN
Jacob Mekhael ... (+2)
  • Jacob Mekhael
  • Thomas Vranken
PREMIUM
HYL Hyloris Pharmac...

Hyloris FIRST LOOK: US deal on tranexamic acid RTU with Avenacy

Hyloris announced an exclusive license and supply agreement with Avenacy for tranexamic acid RTU in the US. The deal is set up as a profit sharing agreement with commercialisation expected to start in 2025. We reiterate our € 5 TP and Hold rating.

HYL HYLORIS PHARMACEUTICALS
12/27/24 December 27, 2024 1 EN
 PRESS RELEASE
Free
AGS AGEAS SA/NV

Ageas reports on the progress of share buy-back programme

Ageas reports on the progress of share buy-back programme Further to the initiation of the share buy-back programme announced on 28 August 2024, Ageas reports the purchase of 50,094 Ageas shares in the period from 16-12-2024 until 20-12-2024. DateNumber ofSharesTotal amount(EUR)Average price(EUR)Lowest price(EUR)Highest price(EUR)16-12-20249,450448,07347.4247.3047.7817-12-20249,234433,16346.9146.7047.3218-12-20249,690449,62146.4046.1046.9219-12-20249,720447,01445.9945.7046.1820-12-202412,000550,18745.8545.5446.20Total50,0942,328,05846.4745.5447.78 Since the start of the share buy-back progr...

December 23, 2024 1 EN
 PRESS RELEASE
Free
AGS AGEAS SA/NV

Rapport d’Ageas sur le programme de rachat d’actions

Rapport d’Ageas sur le programme de rachat d’actions Dans le cadre du programme de rachat d’actions annoncé le 28 août 2024, Ageas indique que 50.094 actions Ageas ont été achetées durant la période du 16-12-2024 au 20-12-2024. DateNombred’actionsMontant total(EUR)Cours moyen(EUR)Cours le plus bas (EUR)Cours le plus élevé (EUR)16-12-20249.450448.07347,4247,3047,7817-12-20249.234433.16346,9146,7047,3218-12-20249.690449.62146,4046,1046,9219-12-20249.720447.01445,9945,7046,1820-12-202412.000550.18745,8545,5446,20Total50.0942.328.05846,4745,5447,78 Depuis le lancement du programme de rachat d’a...

December 23, 2024 1 EN
 PRESS RELEASE
Free
AGS AGEAS SA/NV

Ageas rapporteert over de inkoop van eigen aandelen

Ageas rapporteert over de inkoop van eigen aandelen Naar aanleiding van het aandelen-inkoopprogramma dat op 28 augustus 2024 aangekondigd werd, maakt Ageas bekend dat er 50.094 eigen aandelen ingekocht werden tussen 16-12-2024 en 20-12-2024. DatumAantalaandelenTotaal Bedrag(EUR)Gemiddelde koers(EUR)Laagste koers(EUR)Hoogste koers(EUR)16-12-20249.450448.07347,4247,3047,7817-12-20249.234433.16346,9146,7047,3218-12-20249.690449.62146,4046,1046,9219-12-20249.720447.01445,9945,7046,1820-12-202412.000550.18745,8545,5446,20Totaal50.0942.328.05846,4745,5447,78 Vanaf de start van het aandelen-inkoop...

December 23, 2024 1 EN
Jacob Mekhael ... (+2)
  • Jacob Mekhael
  • Thomas Vranken
PREMIUM
SEQUA SEQUANA MEDICAL

Sequana Medical FDA approval for alfapump

Sequana receives a nice Christmas present this year as it obtained PMA approval from the FDA for its alfapump system in the treatment of r/r ascites due to liver cirrhosis, ahead of the guided 1Q25 timeline. We see the approval as an important derisking event for the company, which will enable the company to address a market opportunity of $ >2bn (mgmt. estimates) in the US. The commercialisation intends to specifically target 90 liver transplant centres and is expected to launch in 2H25. We not...

12/23/24 December 23, 2024 1 EN
Hilde Van Boxstael ... (+3)
  • Hilde Van Boxstael
  • Thomas Vranken
  • Wim Lewi
FAGR FAGRON SA
SEQUA SEQUANA MEDICAL
12/23/24 December 23, 2024 1 EN
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest
Save

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search
Save

ResearchPool Subscriptions

Get the most out of your insights

Get in touch